PPCB
Propanc Biopharma, Inc.
+0.02 (+2.36%)0.65USD324K成交股數37.0M市值0.4本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 6 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 170K | 20K | 60K | 54K | 54K | 54K | 62K | 65K | 114K | 16K | 6K | 66K |
| 銷售管理費用 | 6.2M | 3.6M | 4.6M | 3.6M | 53.1M | 154K | 221K | 349K | 318K | 394K | 197K | 312K |
| 營業利益 | −6.4M-88% | −3.7M+1613% | −4.7M+1507% | −3.6M+766% | −53.1M+12028% | −213K-49% | −291K+39% | −421K+9% | −438K | −417K | −210K | −386K |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −6.4M-88% | −3.1M+619% | −4.8M+1265% | −4.1M+673% | −54.1M+9152% | −430K+23% | −354K-53% | −527K-35% | −584K | −351K | −748K | −810K |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -7.09-98% | -0.30-99% | -0.39-99% | 9.44-102% | -312.46-80% | -32.23+80475% | -35.97-2910% | -545.79+129850% | -1559.55 | -0.04 | 1.28 | -0.42 |
| 稀釋股數 | 897K | 13.4M | 12.3M | 159K | 173K | 13.3K | 9.8K | 994 | 397 | 11.0M | 1.7M | 1.9M |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | – | – | – | – | – | – | – | – | – | – | – | 93K |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 14.3M | 15.1M | 18.0M | 19.6M | 22.5M | 79K | 64K | 37K | 242K | 180K | 60K | 144K |
| 有息負債 | 55K | 55K | 107K | 538K | 439K | 410K | 382K | 583K | 688K | 397K | 391K | 520K |
| 總負債 | 3.5M | 3.7M | 3.6M | 5.7M | 4.4M | 4.2M | 4.2M | 3.7M | 3.8M | 3.2M | 3.2M | 3.1M |
| 股東權益 | 9.8M | 10.5M | 14.4M | 13.9M | 18.1M | −4.2M | −4.1M | −3.7M | −3.6M | −3.0M | −3.1M | −2.9M |
| 負債比 | 24.5% | 24.2% | 20.1% | 29.2% | 19.7% | 5,395.6% | 6,554.8% | 10,008.4% | 1,573.1% | 1,757.3% | 5,267.1% | 2,146.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | −426K |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | −1.9M+723% | – | – | – | −236K | – | – | −333K | – | – |
| 資本支出 | – | – | 2K | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | −1.9M | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −58.9M | –% | -371.22 | – |
| FY2024 | – | – | −1.8M | –% | -35324.35 | – |
| FY2023 | – | – | −2.7M | –% | -1.80 | – |
| FY2022 | – | – | −2.7M | –% | -49.23 | – |
| FY2021 | – | – | −2.0M | –% | -0.80 | – |
| FY2020 | – | – | −4.7M | –% | -192.45 | – |
| FY2019 | – | – | −5.8M | –% | -10.97 | −2.1M |